Duk Lee - Blog & Notes

Writing

• Oct 12, 2026
  The 50-Year Trajectory of Clinical Trial Attrition: Why Failure Rates Rose from 80% to 92% and the Structural Reality Behind Eroom’s Law
• Oct 12, 2026
  The Inverted Dose Trap: Why Martin Shkreli Calls Bristol Myers Squibb’s ($BMY) Phase 3 ALOFT-IPF Trial a Failure
• Oct 12, 2026
  Hacker News Front Page Roundup — October 12, 2026
• Oct 12, 2026
  The AI Capability Funnel: Why 99.8% of the World Thinks AI Is Stalling While 0.2% Experiences Vertigo
• Oct 11, 2026
  The Skeptic’s Deep Dive into AI in Biology: What Is Actually Working in Biopharma, What Failed, and What’s Holding It Back